Robert Eisenbach

Of Counsel
Full contact info

For 30+ years I have been focused on getting results for clients by keeping an eye on the big picture, offering expertise and good judgment and keeping a cool head.

Experience

Mabwell Bioscience Announces Formation of Kalexo Bio With Aditum Bio

September 17, 2025

Cooley advised Mabwell Bioscience, an innovation-driven biopharmaceutical company with capabilities spanning the entire pharmaceutical value chain, on its exclusive license agreement with Aditum Bio to launch Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop 2MW7141, a novel dual-target small interfering RNA (siRNA) candidate for lipid management in patients with dyslipidemia and for the prevention of high-risk atherosclerotic cardiovascular disease events.

Read more

Related contacts

Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Ken Rollins
Partner in Charge – San Diego, San Diego
Brett Dovman
Associate, San Diego
Jeffrey J. Tolin
Partner, New York
Amanda Pacheco
Associate, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
Christopher Kimball
Partner, Washington, DC
David Burns
Special Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

September 5, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its exclusive license agreement with Braveheart Bio for HRS-1893, a small-molecule inhibitor of cardiac myosin independently developed by Hengrui Pharma with best-in-class potential.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Freddy Yip
Associate, Hong Kong
Steve Przesmicki
Partner, San Diego
Navya Dasari
Associate, New York
Max Levinbook
Associate, San Diego
Jeffrey J. Tolin
Partner, New York
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
Christopher Kimball
Partner, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines

July 27, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its up to $12.5 billion agreement with GSK to develop up to 12 medicines to complement GSKs extensive respiratory, immunology and inflammation (RI&I) and oncology pipeline.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Frances Stocks Allen
Partner, London
Jiqiang Lin
Associate, New York
Freddy Yip
Associate, Hong Kong
Aaron Pomeroy
Partner, Colorado
David Wilson
Partner, London
Dr. Xiaozhen (Shawn) Yu
Partner, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Robert Eisenbach
Of Counsel, San Francisco
Navya Dasari
Associate, New York
Rick Jantz
Associate, Santa Monica
Eerik Kukebal
Associate, London
Daniel Millard
Associate, London
Patrick Sharma
Associate, Santa Monica
Zhijing Yu
Associate, Singapore

Related Practices & Industries

Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]

July 25, 2025

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, Washington, DC
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

June 23, 2025

Cooley advised Otsuka Pharmaceutical, a total healthcare company focused on each individual’s potential to enhance their well-being, on its global strategic collaboration with Harbour BioMed to advance BCMAxCD3 bispecific T-cell engagers for treating autoimmune diseases.

Read more

Related contacts

Jennifer Raab
Partner, Palo Alto
Alison Freeman-Gleason
Of Counsel, Seattle
Rachel Thorn
Of counsel, New York
Zack Gong
Associate, Shanghai
Freddy Yip
Associate, Hong Kong
Jonathan Kaufman
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

View more

Admissions and credentials

California

Rankings and accolades

Northern California Super Lawyers

Best Lawyers in America

Memberships and affiliations

American Bankruptcy Institute, member

American Bar Association (ABA)

Bay Area Bankruptcy Forum

Turnaround Management Association

The best in the business

Legal 500 US

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.